Trifluoromethanesulfonic Acid

Trifluoromethanesulfonic Acid

SCHEMBL1462277

C=CC(=O)O.O=S(=O)(O)C(F)(F)F

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.53
ALDH1A1 P00352 3/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
ALOX15 P16050 1/20 0.34
HSD17B10 Q99714 1/20 0.34
CA1 P00915 2/20 0.31
CA2 P00918 2/20 0.31
TSHR P16473 1/20 0.30
FGFR4 P22455 1/20 0.30
CA7 P43166 1/20 0.30
CA13 Q8N1Q1 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoromethanesulfonamide SCHEMBL25383981 0.82 CA1 (0.55) LMNAALDH1A1L3MBTL1ALOX15HSD17B10
Trifluoromethanesulfonic Acid SCHEMBL7781126 0.80 ALDH1A1 (0.39) ALDH1A1L3MBTL1CA1CA2TSHR
Trifluoromethanesulfonic Acid SCHEMBL9332264 0.80 ALDH1A1 (0.42) ALDH1A1L3MBTL1
Acrylic Acid SCHEMBL3399482 0.80 LMNA (0.71) LMNAALDH1A1L3MBTL1ALOX15HSD17B10
Acrylic Acid SCHEMBL1726999 0.80 LMNA (0.71) LMNAALDH1A1L3MBTL1ALOX15HSD17B10
Acrylic Acid SCHEMBL9159882 0.80 LMNA (0.71) LMNAALDH1A1L3MBTL1ALOX15HSD17B10
Acrylic Acid SCHEMBL28311329 0.79 LMNA (0.53) LMNAALDH1A1L3MBTL1ALOX15HSD17B10
Trifluoromethanesulfonic Acid SCHEMBL28499740 0.78 ALDH1A1 (0.38) ALDH1A1L3MBTL1CA1CA2TSHR
Trifluoromethanesulfonic Acid SCHEMBL21176050 0.78 CA1 (0.40) ALDH1A1L3MBTL1CA1CA2TSHR
Trifluoromethanesulfonic Acid SCHEMBL29596747 0.78 ALDH1A1 (0.38) ALDH1A1L3MBTL1CA1CA2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2070507-B1 Hardening composition DENTSPLY DETREY GMBH (DE) 2013-09-04 EP disclosed
US-8440740-B2 Dental glass compositions utilizing a glass ionomer and an acidic copolymer DENTSPLY INTERNATIONAL INC. (US) 2013-05-14 US disclosed
US-20110071233-A1 HARDENING COMPOSITION BLACKWELL GORDON 2011-03-24 US disclosed
WO-2009077113-A2 HARDENING COMPOSITION DENTSPLY DETREY GMBH (DE) 2009-06-25 WO disclosed
EP-2070507-A1 Hardening composition Dentsply DeTrey GmbH (DE) 2009-06-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110071233-A1 HARDENING COMPOSITION H1-0, H1-5, H1-4 LMNA 3184/4885ALDH1A1 3330/4885L3MBTL1 3282/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.